AAA

Advanced Proteome Therapeutics Corp.

No trades
See on Supercharts
Market capitalization
‪150.30 K‬USD
‪36.65 M‬
Beta (1Y)
0.59

About ADVANCED PROTEOME THERAPEUTICS CORP

CEO
Paul Woodward
Headquarters
Burnaby
Founded
2005
FIGI
BBG000FGQL84
Advanced Proteome Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of a new technology platform that is intended for the chemical modification of protein therapeutics. The firm's technology is applicable to the rapid growth areas of therapeutics and diagnostics, Protein Drugs, and Personalized Medicine, respectively, and is being applied to cancer therapeutics in the field of antibody-drug conjugates. The company was founded by Alexander Krantz on December 12, 2005 and is headquartered in Burnaby, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of APTCF is 0.0002 USD — it has decreased by 99.46% in the past 24 hours. Watch Advanced Proteome Therapeutics Corp. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Advanced Proteome Therapeutics Corp. stocks are traded under the ticker APTCF.
APTCF stock is ‪18.25 K‬% volatile and has beta coefficient of 0.59. Track Advanced Proteome Therapeutics Corp. stock price on the chart and check out the list of the most volatile stocks — is Advanced Proteome Therapeutics Corp. there?
Yes, you can track Advanced Proteome Therapeutics Corp. financials in yearly and quarterly reports right on TradingView.
No, APTCF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, APTCF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Advanced Proteome Therapeutics Corp. stock right from TradingView charts — choose your broker and connect to your account.
APTCF reached its all-time high on May 29, 2008 with the price of 8.4870 USD, and its all-time low was 0.0002 USD and was reached on Jul 28, 2023. View more price dynamics on APTCF chart.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Advanced Proteome Therapeutics Corp. technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Advanced Proteome Therapeutics Corp. stock shows the strong sell signal. See more of Advanced Proteome Therapeutics Corp. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.